Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-08-06
2008-12-02
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S131000, C548S571000
Reexamination Certificate
active
07459472
ABSTRACT:
This invention provides aryl and heteroaryl compounds of Formula (I) as described herein, and methods of their preparation. Also provided are pharmaceutical compositions made with the compounds of Formula (I) and methods for making such compositions. Compounds of Formula (I) may be useful for treating viral infections including orthopox viruses, either alone or in combination with other therapeutic agents.
REFERENCES:
patent: 4675439 (1987-06-01), Mita et al.
patent: 4717736 (1988-01-01), Rokach et al.
patent: 5273990 (1993-12-01), De Lombaert et al.
patent: 5354905 (1994-10-01), Sato et al.
patent: 5397798 (1995-03-01), Fitch et al.
patent: 5514719 (1996-05-01), LaTorse et al.
patent: 5518735 (1996-05-01), Sturzebecher et al.
patent: 5679671 (1997-10-01), Oinuma et al.
patent: 5703106 (1997-12-01), Fruh et al.
patent: 5750520 (1998-05-01), Danilewicz et al.
patent: 5780498 (1998-07-01), Saika et al.
patent: 5908843 (1999-06-01), Gante et al.
patent: 5977075 (1999-11-01), Ksander et al.
patent: 5977178 (1999-11-01), Hansen et al.
patent: 6001820 (1999-12-01), Hirsh et al.
patent: 6087380 (2000-07-01), Hauel et al.
patent: 6093731 (2000-07-01), Dickinson et al.
patent: 6127341 (2000-10-01), Hansen et al.
patent: 6191171 (2001-02-01), DeLaszlo et al.
patent: 6194448 (2001-02-01), Bredrget et al.
patent: 6194458 (2001-02-01), Baker et al.
patent: 6262084 (2001-07-01), Biediger et al.
patent: 6284871 (2001-09-01), Mertens et al.
patent: 6291511 (2001-09-01), Durette et al.
patent: 6300330 (2001-10-01), Stocker et al.
patent: 6306840 (2001-10-01), Adams et al.
patent: 6331564 (2001-12-01), Brugnara et al.
patent: 6342504 (2002-01-01), Brunck et al.
patent: 6358978 (2002-03-01), Ritzeler et al.
patent: 6362204 (2002-03-01), Head et al.
patent: 6388138 (2002-05-01), Lee
patent: 6388148 (2002-05-01), Heilmann et al.
patent: 6403584 (2002-06-01), De Laszlo et al.
patent: 6420396 (2002-07-01), Albers et al.
patent: 6423727 (2002-07-01), De Lombaert et al.
patent: 6469047 (2002-10-01), Jackson et al.
patent: 6521666 (2003-02-01), Sircar et al.
patent: 6528275 (2003-03-01), Quibell et al.
patent: 6528655 (2003-03-01), N'Zemba et al.
patent: 6559174 (2003-05-01), Lin et al.
patent: 6743790 (2004-06-01), Klingler et al.
patent: 6855843 (2005-02-01), Sircar et al.
patent: 6908939 (2005-06-01), Bernardon et al.
patent: 2002/0016461 (2002-02-01), Albers et al.
patent: 2002/0095041 (2002-07-01), Chan et al.
patent: 2002/0103195 (2002-08-01), Curtin et al.
patent: 2002/0151595 (2002-10-01), Ries et al.
patent: 2002/0173656 (2002-11-01), Peyman et al.
patent: 2002/0198195 (2002-12-01), Nazare et al.
patent: 2003/0045480 (2003-03-01), Safar et al.
patent: 2003/0149083 (2003-08-01), Tanaka et al.
patent: 2004/0106626 (2004-06-01), South et al.
patent: 2004/0126856 (2004-07-01), Bajal et al.
patent: 2004/0152888 (2004-08-01), Bourguignon et al.
patent: 2004/0198780 (2004-10-01), Liu et al.
patent: 2004/0220180 (2004-11-01), Glick et al.
patent: 2004/0241781 (2004-12-01), Glick et al.
patent: 2005/0049310 (2005-03-01), Mjalli et al.
patent: 2005/0053600 (2005-03-01), Lane
patent: 2005/0059705 (2005-03-01), Mjalli et al.
patent: 2005/0065346 (2005-03-01), Ries et al.
patent: 2005/0165107 (2005-07-01), Inoue et al.
patent: 2005/0187390 (2005-08-01), Schmitz et al.
patent: 2005/0187409 (2005-08-01), Powers et al.
patent: 2005/0203135 (2005-09-01), Burdick et al.
patent: 2005/0256116 (2005-11-01), Clary et al.
patent: 199 28 424 (2000-12-01), None
patent: 0150118 (1987-09-01), None
patent: 1213288 (2002-12-01), None
patent: 2 847 251 (2004-05-01), None
patent: 1 501 541 (1978-02-01), None
patent: 2354440 (2000-07-01), None
patent: 61-227555 (1986-10-01), None
patent: 09-124569 (1997-05-01), None
patent: 2001-089368 (2001-04-01), None
patent: 2003-321358 (2003-11-01), None
patent: 2004-323487 (2004-11-01), None
patent: WO 96-33170 (1996-10-01), None
patent: WO 97-23508 (1997-07-01), None
patent: WO 97-40065 (1997-10-01), None
patent: WO 97-42216 (1997-11-01), None
patent: WO 98/37075 (1998-08-01), None
patent: WO 95/12611 (1998-11-01), None
patent: WO 98/53817 (1998-12-01), None
patent: WO 98-58950 (1998-12-01), None
patent: WO 99/26923 (1999-06-01), None
patent: WO 99/36393 (1999-07-01), None
patent: WO 00-35864 (2000-06-01), None
patent: WO 00/37429 (2000-06-01), None
patent: WO 00/67746 (2000-11-01), None
patent: WO 00/68188 (2000-11-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 01/10823 (2001-02-01), None
patent: WO 01/21584 (2001-03-01), None
patent: WO 01/38309 (2001-05-01), None
patent: WO 01-056994 (2001-08-01), None
patent: WO 01/68586 (2001-09-01), None
patent: WO 02/18320 (2002-03-01), None
patent: WO 02/26717 (2002-04-01), None
patent: WO 02/062748 (2002-08-01), None
patent: WO 02-083842 (2002-10-01), None
patent: WO 02/085841 (2002-10-01), None
patent: WO 03-002545 (2003-01-01), None
patent: WO 03-006444 (2003-01-01), None
patent: WO 03/007945 (2003-01-01), None
patent: WO 03/033496 (2003-04-01), None
patent: WO 03-072536 (2003-09-01), None
patent: WO 2004/014844 (2004-02-01), None
patent: WO 2004/046091 (2004-06-01), None
patent: WO 2004/080970 (2004-09-01), None
patent: WO 2004/084842 (2004-10-01), None
patent: WO 2004-110983 (2004-12-01), None
patent: WO 2005-012288 (2005-02-01), None
patent: WO 2005-039494 (2005-05-01), None
Srivastava et al., 1981, CAS: 95:125911.
St. Hilaire et al. CAS:141:150947.
Bernardon et al., CAS: 139:101121.
Burdick et al, “N-Benzoyl Amino Acids as LFA-1/ICAM Inhibitors 1: Amino Acid Structure-Activity Relationship” Bioorganic Medicinal Chemistry Letters, vol. 13, pp. 1015-1018 (2003).
Castanedo et al, “Solid-Phase synthesis of dual alpha4beta1/alpha4beta7 Integrin antagonists: Two Scaffolds with Overlapping Pharmacophores”, Bioorganic & Medicinal Chemistry Letters, Oxford, GB vol. 12, pp. 2913-2917 (2002).
Database Caplus Chemical Abstracts Service, Columbus, Ohio, US, XP002319820, rerieed from STN Database accession No. 1973: 504834 abstract; RN 42787-97-3 abstract & I. Hahnemann et al, Journal For Praktische Chemie, vol. 315, No. 4, 1973, pp. 796-800.
Greenspan P.D. et al., “N-aryl Cinnamides: A Novel Class of Rigid and Highly Potent Leukotriene B4 Receptor Antagonists”, Bioorganic and Medicinal Chemistry Letters, vol. 7, pp. 949-954 (1997).
International Search Report for related PCT application PCT/US2004/025463 mailed Jan. 26, 2005.
International Search Report for related PCT application PCT/US2004/025478 mailed Jan. 26, 2005.
International Search Report for related PCT application PCT/US2004/025429 mailed Jan. 26, 2005.
International Search Report for PCT application PCT/US03/25045 mailed Mar. 14, 2005.
Knowles, H.S. et al., “A photochemical approach to phenylalanines and related compounds by alkylation of glycine”, Tetrahedron, vol. 57, pp. 98115-98124 (2001).
O'Donnell M.J. et al., “Enantioselective Solid-Phase Synthesis of α-Amino Acid Derivatives”, Tetrahedron, vol. 55, pp. 6347-6362 (1999).
Sircar et al, “Synthesis and SAR of N-benzoyl-L-Biphenylalanine derivatives: Discovery of TR-14035, A Dual Alpha4Beta7/Alpha4Beta1 Intergrin Antagonist”, Bioorganic & Medicinal Chemistry, vol. 10, pp. 2051-2066 (2002).
Bebernitz et al., “Anilides of R-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase”, Journal of Medicinal Chemistry, vol. 43, pp. 7121-7124, (2000).
Shrader et al., “Neutral Inhibitors of the Serine Protease Factor Xa”, Bioorganic & Medicinal Chemistry Letters, vol. 11, pp. 1801-1804, (2001).
Knowles et al., “Photochemical alkylation of glycine leading to phenylalanines”, Tetrahedron Letters, vol. 41, pp. 7121-7124, (2000).
International Search Report for related PCT application PCT/US2004/025478 mailed Feb. 23, 2006.
Alves et al., “A Novel 3-step Enantioselective Synthesis of Pyrenrlalanine with Subsequent Incorporation Into Opioid, CCK and Melanotropin Ligands” Biochemical and Biophysical Research Communications, vol. 318, pp. 335-
Andrews Robert C.
Arimilli Murty N.
Bondlela Muralidhar
Guo Xiao-Chuan
Guzel Mustafa
Kilpatrick & Stockton LLP
Shiao Rei-tsang
TransTech Pharma, Inc.
LandOfFree
Aryl and heteroaryl compounds, compositions, and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl and heteroaryl compounds, compositions, and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl and heteroaryl compounds, compositions, and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4046061